Sustainable and available sources of omega-3 fatty acids for health: are the current dietary recommendations, food sources and legislation fit for purpose?

Summary

This narrative review reassesses whether the UK's 2004 omega-3 recommendation (>450 mg EPA + DHA per day) remains adequate, drawing on recent evidence from randomised trials suggesting doses of ≥1.5 g/day are needed for meaningful anti-inflammatory and metabolic benefits. The authors note that farmed salmon now delivers substantially less EPA + DHA than two decades ago, and that oily fish alone cannot meet global population needs. They propose a portfolio of alternative sources—including algal oils, bio-enriched animal products, fortified foods, and genetically modified oilseeds—and call for policy and research attention to sustainability and accessibility across diverse dietary patterns.

Regional applicability

The study is UK-focused, as it directly evaluates UK dietary recommendations and food policy. The findings have direct applicability to UK nutrition guidance and food standards policy; however, the sustainability and availability challenges identified (dependence on oily fish, global supply constraints) are internationally relevant, and the proposed alternatives (algal oils, bio-enriched products, GM oilseeds) may require UK policy recalibration around food fortification standards and labelling.

Key measures

EPA + DHA intake recommendations (mg/day); EPA + DHA content in farmed salmon and oily fish; typical global and population-specific intakes; evidence from randomised controlled trials on effective doses for anti-inflammatory, lipid-lowering, and cognitive outcomes

Outcomes reported

The review evaluates whether current UK EPA + DHA intake recommendations (>450 mg/day, last revised 2004) remain fit for purpose in light of emerging evidence, changing fish composition, and global sustainability constraints. It identifies alternative sources and discusses whether recommendations should be revised upwards.

Topic tags